Davida Krueger

Title: Davida Krueger: Innovator in Diabetes Treatment

Introduction

Davida Krueger is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Type 2 diabetes. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Krueger's latest patents focus on crystalline forms of dipeptidyl peptidase-IV inhibitors. These novel crystalline forms of (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine are recognized as potent inhibitors of dipeptidyl peptidase-IV. They are particularly useful for the treatment of non-insulin dependent (Type 2) diabetes mellitus. The invention also encompasses pharmaceutical compositions containing these novel forms, processes to prepare these forms, and their applications in treating Type 2 diabetes.

Career Highlights

Krueger is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes for individuals suffering from diabetes.

Collaborations

Throughout his career, Krueger has collaborated with talented individuals such as Itzia Arroyo and Ping Chen. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in diabetes treatment.

Conclusion

Davida Krueger's contributions to the field of diabetes treatment through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmaceutical therapies.